Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06168058 · ClinicalTrials.gov registry record · NA

Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices

A NA study of Pelvic Pain and Chronic Pelvic Pain Syndrome, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
3
Study locations

NCT06168058: Recruiting NA study of Pelvic Pain and Chronic Pelvic Pain Syndrome, sponsored by Weill Medical College of Cornell University.

NCT06168058 is a NA study of Pelvic Pain and Chronic Pelvic Pain Syndrome that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 40 participants, below the 370-participant average among 23 other Pelvic Pain trials with a reported enrollment target (89% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06168058, a NA study of Pelvic Pain and Chronic Pelvic Pain Syndrome, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to see if a randomized controlled trial of ovarian vein and pelvic vein embolization versus venography alone could determine outcomes for women with chronic pelvic pain and pelvic varicose veins. The data gathered will assist in addressing changes in quality of life in patients who have ovarian/pelvic vein embolization versus no embolization.

Primary Outcome

The VAS pain score is a standard scale from 0 to 10, defining 0 as ''no pain'' and 10 ''worst pain possible.''

Interventions

  • DIAGNOSTIC_TEST Transcatheter Venography
  • PROCEDURE Bilateral ovarian vein embolization

Study Locations (3)

New York

  • Weill Cornell Medicine - New York

North Carolina

  • UNC School of Medicine - Chapel Hill

Washington

  • Lake Washington Vascular - Bellevue

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-08-07
Est. Completion 2027-06
Phase NA

What NCT06168058 shows while recruiting

NCT06168058 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 370-participant average among 23 other Pelvic Pain trials with a reported enrollment target (89% lower).

The record links to 5 conditions, with Pelvic Pain appearing as the primary indexed condition, and to 2 interventions - of which Transcatheter Venography is the first listed.

NCT06168058 reports a single indexed study location in New York, North Carolina, Washington.

Frequently Asked Questions

What is clinical trial NCT06168058 about?

NCT06168058 is a clinical study titled "Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices". The purpose of this study is to see if a randomized controlled trial of ovarian vein and pelvic vein embolization versus venography alone could determine outcomes for women with chronic pelvic pain and pelvic varicose veins. The data gathered will assist in addressing changes in quality of life in ...

What is the current status of trial NCT06168058?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-08-07. Estimated completion is 2027-06.

What conditions does trial NCT06168058 study?

This clinical trial studies the following conditions: Pelvic Pain, Chronic Pelvic Pain Syndrome, Pelvic Congestive Syndrome, Pelvic Varices, Pelvic Pain Syndrome.

What interventions are being tested in trial NCT06168058?

The interventions under investigation include: Transcatheter Venography (DIAGNOSTIC_TEST), Bilateral ovarian vein embolization (PROCEDURE).

Who is sponsoring clinical trial NCT06168058?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06168058 being conducted?

This trial has 3 study locations across New York, North Carolina, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pelvic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06168058's enrollment target sits among peer trials

40 18th of 23 higher than 6 of 23 other Pelvic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pelvic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06168058, the US trial registry maintained by the National Library of Medicine. NCT06168058 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.